A Case Report of Type 1 Brugada Syndrome with Scn5a Mutation Augmented by Fever
International Journal of Cardiology and Cardiovascular Disorder · 2023
DOI: 10.47485/2998-4513.1020 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Cardiology and Cardiovascular Disorder, 2023. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Brugada syndrome is an inherited disorder characterized by a channelopathy of cardiac sodium, potassium, and calcium channel. The pathophysiology of this disorder is not completely elucidated yet, however, most of the reported cases are caused by a pathogenic alteration in the SCN5A gene, leading to the malfunction of cardiac sodium channels. Three ECG patterns are frequently described in the literature, type 1, type 2, and type 3. However, only the type 1 pattern is considered diagnostic of Brugada syndrome in the appropriate clinical context. Therapeutic strategies can range from conservative medical management with antiarrhythmic medications to Implantable Cardioverter Defibrillator placement. Prompt recognition is of utmost importance since this pathology can rapidly evolve into life-threatening arrhythmias and sudden cardiac death. Here we present a case of a 20-year-old male who presented after a surgery and with clinical findings of Brugada syndrome in which the patient suffered from brain damage post-resuscitation due to cardiac arrest.
Zitieren
APA
(2023). A Case Report of Type 1 Brugada Syndrome with Scn5a Mutation Augmented by Fever. International Journal of Cardiology and Cardiovascular Disorder. https://doi.org/10.47485/2998-4513.1020
Vancouver
A Case Report of Type 1 Brugada Syndrome with Scn5a Mutation Augmented by Fever. International Journal of Cardiology and Cardiovascular Disorder. 2023. doi:10.47485/2998-4513.1020
BibTeX
@article{euvimed2023,
title = {A Case Report of Type 1 Brugada Syndrome with Scn5a Mutation Augmented by Fever},
journal = {International Journal of Cardiology and Cardiovascular Disorder},
year = {2023},
doi = {10.47485/2998-4513.1020}
}
EUVIMED